推荐产品
product name
Fluoroshield ™ 与 1,4-二氮杂双环 [2.2.2] 辛烷, pH range 8.0-8.4, Aqueous mounting medium
质量水平
形式
liquid
技术
immunofluorescence: suitable
pH值范围
8.0-8.4
应用
diagnostic assay manufacturing
hematology
histology
储存温度
2-8°C
一般描述
含 1,4-二氮杂双环 [2.2.2] 辛烷的 Fluoroshield™ 是一种水性封固剂，用于保存组织和细胞涂片的荧光。
应用
含 1,4-二氮杂双环 [2.2.2] 辛烷的 Fluoroshield™ 可防止 FITC、Texas Red®、AMCA、™ 488、Alexa Fluor 594、Cy® 染料和四甲基罗丹明的快速光漂白效应。
原理
含 1,4-重氮杂环[2.2.2]辛烷封固剂的 Fluoroshield™ 使用 1,4-重氮杂环[2.2.2]辛烷（DABCO® 的通用版本）强化，这是一种抗褪色试剂，用于延缓荧光素和其他荧光染料的光漂白。
法律信息
ALEXA FLUOR is a trademark of Life Technologies
Cy is a registered trademark of Cytiva
DABCO is a registered trademark of Air Products & Chemicals, Inc.
FluoroShield is a trademark of ImmunoBioScience Corp.
Texas Red is a registered trademark of Life Technologies
警示用语：
Danger
危险声明
危险分类
Eye Dam. 1
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Ibtisam A Abbas Al-Darkazly et al.
IEEE journal of translational engineering in health and medicine, 8, 4100113-4100113 (2020-01-31)
Objective: investigation of the extra-low-frequency (ELF) stimulation effect on blood-cell proteins, that causes variation in its electrostatic-state. A hypothesis that this results in the conformational change in the blood-cell proteins which could enhance immune activity is explored. Since HIV-1 and
Nour W Al Haj Baddar et al.
Developmental dynamics : an official publication of the American Association of Anatomists, 248(2), 189-196 (2018-12-21)
Among vertebrates, salamanders are unparalleled in their ability to regenerate appendages throughput life. However, little is known about early signals that initiate regeneration in salamanders. Ambystoma mexicanum embryos were administered tail amputations to investigate the timing of reactive oxygen species
Morphological changes of cortical and hippocampal neurons after treatment with VEGF and bevacizumab.
Latzer P, et al.
CNS Neuroscience & Therapeutics, 22(6), 440-450 (2016)
Anna Wolters et al.
Neural regeneration research, 16(11), 2243-2249 (2021-04-06)
One of the major challenges in emergency medicine is out-of-hospital cardiac arrest (OHCA). Every year, about 53-62/100 000 people worldwide suffer an out-of-hospital cardiac arrest with serious consequences, whereas persistent brain injury is a major cause of morbidity and mortality
Mariana L Casalia et al.
Annals of neurology, 82(4), 530-542 (2017-08-24)
A significant proportion of the more than 50 million people worldwide currently suffering with epilepsy are resistant to antiepileptic drugs (AEDs). As an alternative to AEDs, novel therapies based on cell transplantation offer an opportunity for long-lasting modification of epileptic
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门